The largest database of trusted experimental protocols

8 protocols using hla dr antibody

1

Characterization of MSC Surface Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
The characteristics of MSCs (p6) isolated from ten independent donors were analyzed by flow cytometry. MSCs were collected and labeled with fluorescein isothiocyanate (FITC)-conjugated human CD14, CD45, and human leukocyte antigen (HLA)-DR antibodies (BD Biosciences, Franklin Lakes, NJ, USA). Phycoerythrin (PE)-conjugated human CD73, CD166 (BD Biosciences), CD90, and CD105 (Invitrogen, Carlsbad, CA, USA) antibodies were used to measure stem cell surface markers on MSCs. An isotype control was also included. Washed MSCs were fixed with 1% (v/v) paraformaldehyde (Sigma-Aldrich). Stained cells were analyzed by flow cytometry on a MACSQuant instrument (Miltenvi Biotec, Bergisch Gladbach, Germany).
+ Open protocol
+ Expand
2

Isolation and Characterization of HUCMSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
HUCMSC were isolated and characterized as previously described (9 (link)). Briefly, umbilical cord tissues from healthy women were washed three times and cut into approximately 1 mm3 pieces. The pieces evenly spread on the bottom of a 75cm2 flask with the serum-free MSC culture medium (TBD Science, China) for primary adherent culture and cultured in a 5% CO2 incubator at 37°C. The medium was refreshed every 3-4 days. After achieving 80%–90% confluence, the cells were digested with 0.25% trypsin-EDTA (Gibco, Carlsbad, CA, USA) 2 minutes for passaging. The cells were seeded into 175cm2 flasks at a density of 6000-8000 cells/cm2. Until the cell confluence reached 80%-90%, the cells were digested and collected to obtain the passage one of HUCMSC. Repeat the above operations for subculture. HUCMSC at passage five were characterized by morphology, mesenchymal lineage differentiation and surface marker expression. The capacity of osteogenic, adipogenic, and chondrogenic mesenchymal lineage differentiation was detected using Alizarin Red, Oil Red O, and Alcian Blue staining (OriCell, Guangzhou, China), respectively. Surface marker expression was also characterized by flow cytometry with CD73, CD90, CD105, CD34, CD14 and HLA-DR antibodies (BD Bioscience, San Jose, CA, USA) as described by previous study (20 (link)). Then the cells were used for further experiments.
+ Open protocol
+ Expand
3

PBMCs Culturing and Immunophenotyping

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMCs were cultured in RPMI 1640 medium (Capricorn) supplemented with 10% AB human serum (Sigma), 1% sodium pyruvate 100 mM (Gibco), 1% nonessential amino acids (Gibco), 1% HEPES buffer (Gibco), 0.5% of β-mercaptoethanol 10−2 M (Gibco), and 0.2% of 10 mg/ml gentamicin (Gibco).
The recombinant form of PpSP32 was produced as described previously [22 (link)]. The following monoclonal antibodies were used for flow cytometry analysis: fluorescein isothiocyanate (FITC), allophycocyanin (APC), and phycoerythrin (PE) conjugated with anti-cluster of differentiation (CD)14, anti-CD86, and human leukocyte antigen receptor (HLA-DR) antibodies, respectively, (BD Biosciences).
+ Open protocol
+ Expand
4

Surface Marker Expression of hES-MP Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The surface marker expression of hES-MP cells was evaluated with flow cytometry after expansion in either 10% hPL (hPL–hES-MP) or 10% FBS (FBS–hES-MP) for 4, 6, and 10 passages. Cells were stained with CD10, CD13, CD29, CD44, CD45, CD73, CD105, CD184, and HLA-DR antibodies (BD Biosciences, San Jose, CA, USA) according to manufacturer’s instructions and then fixed with 0.5% paraformaldehyde (Sigma-Aldrich) in phosphate-buffered saline (PBS, Gibco). Appropriate isotype-matched controls were used as negative controls. Samples were measured with a FACSCalibur flow cytometer equipped with an argon ion laser (BD Biosciences) and subsequently analyzed using Cellquest Pro software (BD Biosciences). Cells were gated according to their side scatter and forward scatter profiles.
Note that at the time of this study, we were unable to test for CD90. However, in subsequent work (unpublished data), the same batches of hES-MP cells were confirmed to be positive for CD90.
+ Open protocol
+ Expand
5

Lipid-based Nanoparticle Formulation and Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
All lipids including 1,2-distearoyl-sn-glycero-3-phos-phocholine (DSPC; 20 mM), cholesterol (CHOL; 10 mM) and N-[1-(2,3-Dioleoyloxy) propyl]-N,N,N- trimethyl ammonium methyl-sulfate (DOTAP; 20 mM) were purchased from Avanti Polar Lipid (Alabaster, USA). The fluorescent lipophilic dyes, 1,1_-dioctadecyl-3,3,3_,3_-tetramethylindocarbocyanine perchlorate (DiI) and 1,1_-dioctadecyl-3,3,3_,3_ tetramethylindodicarbocyanine (DiD) were purchased from Invitrogen (USA). Bovine serum albumin (BSA) was from Fluka (USA). 4-(2-hyd roxyethyl)-1 piperazineethanesulfonic acid (HEPES), Iscove’s Modified Dulbecco’s Medium (IMDM), Roswell Park Memorial Institute (RPMI) 1640 medium and phosphate-buffered saline (PBS; 155 mM NaCl, 1.5 mM potassium phosphate monobasic, 2.7 mM sodium phosphate dibasic, pH 7.2) were from Sigma (USA), human granulocyte macrophage colony-stimulating factor (GM-CSF), murine GM-CSF, human IL-4 and murine IL-4 were from R&D (USA). L-Glutamine was from Biosera. Anti-murine FITC conjugated CD11c and PE conjugated CD40, CD80, CD86, MHC-II and anti-human FITC conjugated CD14 and PE conjugated CD83, CD86 and HLA-DR antibodies were from BD Biosciences (USA). Lipopolysaccharide (LPS) was from Sigma (USA). Fetal calf serum (FCS) were purchased from Invitrogen (USA). CD14 human microbeads (Cat. No.#130-050-201) were purchased from Miltenyi Biotec (Germany).
+ Open protocol
+ Expand
6

UC-MSC Surface Marker Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Flow cytometry (BD, USA) analysis was performed to assay the surface marker expressions of UC-MSCs. Cells in 100 μL PBS (Hyclone, China) were incubated with CD34, CD45, CD73, CD90, CD105 and HLA-DR antibodies (BD, USA) conjugated with FITC or PE for 15 min in darkness. The cells were assayed by Flow cytometry (BD, USA), and the original data were analyzed using the Flowjo software (version 10).
+ Open protocol
+ Expand
7

Maturation of Dendritic Cells Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The maturation of DCs was detected by flow cytometry after 24 hours pharmacological intervention by KU0063794 and matrine, using CD83 antibody, CD86 antibody and HLA-DR antibody (BD Biosciences, Franklin Lakes, NJ, USA) [8 (link)].
+ Open protocol
+ Expand
8

Immunophenotyping of Dental Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
To verify the expression surface markers, SHEDs at in vitro passage 6 (P6) were utilized. For each condition, 3 lines of SHEDs derived from 3 different donors were analyzed (total n = 9). The SHEDs were dissociated and cultured within 48 h after tooth extraction. Cells were suspended at FACS buffer consisting of Dulbecco's modified phosphate buffered saline (DPBS) (Welgene, Daegu, South Korea) containing 2% FBS (2 × 105 cells/100 μL). Cells were incubated with the following primary antibodies according to the suggested dilution factor for 20 min at RT; anti-human CD11b, CD14, CD19, CD34, CD44, CD45, CD73, CD90, CD105, CD166, or HLA-DR antibody (BD Biosciences, NJ, USA). After washing by FACS buffer three times, the fluorescence intensity was measured using a FACS Calibur (BD Biosciences). FLOWJO software (Tree Star Inc., Ashland, OR, USA) was used for data analysis. Positive cells were determined by comparing with the appropriate isotype controls (BD Biosciences).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!